Human C1-Esterase inhibitor concentrate (Berinert®)

BioDrugs

Volumn 23, Issue 6, 2009, Pages 399-406

  Keating, Gillian M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; PLACEBO;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; ANTIINFLAMMATORY ACTIVITY; BACKACHE; CLINICAL TRIAL; DERMATOLOGY; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; DYSGEUSIA; HEALTH SURVEY; HUMAN; LARYNX EDEMA; MUSCLE SPASM; NAUSEA; PAIN; PERIPHERAL EDEMA; PRIORITY JOURNAL; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; SHORT FORM 36; SINGLE DRUG DOSE; SKIN SWELLING; UNSPECIFIED SIDE EFFECT; VOMITING;

COMPLEMENT C1 INHIBITOR PROTEIN; HEREDITARY ANGIOEDEMA TYPES I AND II; HUMANS; INFUSIONS, INTRAVENOUS; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF ADMINISTRATION;

EID: 70450201071     PISSN: 11738804     EISSN: 1179190X     Source Type: Journal    
DOI: 10.2165/11201100-000000000-00000     Document Type: Review

References (28)

1. Bowen T, Cicardi M, Bork K, et al. Hereditary angioedema: A current stateof- the-art review, VII: Canadian Hungarian 2007 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. Ann Allergy Asthma Immunol 2008 Jan; 100 (1 Suppl. 2): S30-40
2. Davis III AE. New treatments addressing the pathophysiology of hereditary angioedema. Clin Molecul Allerg 2008 Apr 14; 6: 2
3. Bork K. Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions. Expert Rev Clin Immunol 2008; 4 (1): 13-20
4. Longhurst HJ. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitors deficiency: what is the evidence? Int J Clin Pract 2005 May; 59 (5): 594-599
5. Cicardi M, Zingale LC. The deficiency of C1 inhibitor and its treatment. Immunobiology 2007; 212 (4-5): 325-331
6. Zuraw BL. Clinical practice: hereditary angioedema. NEngl JMed 2008 Sep 4; 359 (10): 1027-1036
7. Cugno M, Cicardi M, Bottasso B, et al. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood 1997 May 1; 89 (9): 3213-3218
8. Davis III AE. The pathophysiology of hereditary angioedema. Clin Immunol 2005 Jan; 114 (1): 3-9
9. CSL Behring. Berinert (C1-esterase inhibitor, human): UK summary of product characteristics [online]. Available from URL: http://emc.medicines.org. uk/medicine/21650/SPC/Berinert/ [Accessed 2009 Aug 27]
10. Groner A, Nowak T, Schafer W. An integrated approach to effective pathogen reduction for a plasma-derived C1 inhibitor concentrate [poster]. 52nd Annual Meeting of the Society of Thrombosis and Haemostasis Research; 2008 Feb 20-23; Wiesbaden
11. De Serres J, Groner A, Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert-P) in hereditary angioedema: A review. Transfus Apher Sci 2003 Dec; 29 (3): 247-254
12. Bernstein JA. Hereditary angioedema: A current state-of-the-art review, VIII: current status of emerging therapies. AnnAllergyAsthma Immunol 2008 Jan; 100 (1 Suppl. 2): S41-6
13. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005 Mar; 139 (3): 379-394
14. Martinez-Saguer I, Rusicke E, Aygoren-Pursun E, et al. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: A prospective study. Transfusion (Paris). Epub 2009 Sep 24
15. Beinrohr L, Harmat V, Dobó J, et al. C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease. J Biol Chem 2007 Jul 20; 282 (29): 21100-21109
16. Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared to placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009 Oct; 124 (4): 801-808
17. Craig TJ, Wasserman RL, Levy R, et al. C1-esterase inhibitor (C1-INH) - standard of care for the treatment of acute attacks in hereditary angioedema (HAE): Initial results of an ongoing, prospective, open-label study of North America (I.M.P.A.C.T.2) [poster]. 64th Annual Meeting of the American Academy of Asthma, Allergy, and Immunology; 2008 Mar 14-18; Philadelphia (PA)
18. Bork K, Barnstedt S-E. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 2001 Mar 12; 161: 714-718
19. Bork K, Staubach P, Hardt J. Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema. Allergy 2008 Jun; 63 (6): 751-757
20. BorkK,MengG, Staubach P, et al. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 2005 Nov; 45 (11): 1774-1784
21. Farkas H, Jakab L, Temesszentandrá si G, et al. Hereditary angioedema: A decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol 2007 Oct; 120 (4): 941-947
22. Kreuz W,Martinez-Saguer I, Aygoren-Pursun E, et al. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Transfusion 2009 Sep; 49 (9): 1987-1995
23. Bygum A, Andersen KE, Mikkelsen CS. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur J Dermatol 2009 Mar-Apr; 19 (2): 147-151
24. Longhurst HJ, O'Grady C. Home therapy for HAE: the Barts experience [abstract]. J Allergy Clin Immunol 2004 Sep; 114 (3 Suppl.): S99-100
25. Rusicke E, Martinez-Saguer I, Aygoren-Pursun E, et al. Home treatment in patients with hereditary angioedema (HAE) [abstract no. 700]. J Allergy Clin Immunol 2006 Feb; 117 (2 Suppl. 1): S180
26. Longhurst HJ, Carr S, Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: A viable, effective treatment option. Clin Exp Immunol 2007 Jan; 147 (1): 11-17
27. Bork K, Hardt J. Hereditary angioedema: Increased number of attacks after frequent treatments with C1 inhibitor concentrate. Am J Med 2009 Aug; 122 (8): 780-783
28. CSL Behring. Berinert- (C1 esterase inhibitor [human]) [online]. Available from URL: http://www.fda.gov/downloads/BiologicsBloodVaccines/Blood BloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasma Products/UCM186268.pdf [Accessed 2009 Oct 13]